| Trial ID: | L6514 |
| Source ID: | NCT00561171
|
| Associated Drug: |
Spp635
|
| Title: |
Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Type II Diabetes Mellitus
|
| Interventions: |
DRUG: SPP635
|
| Outcome Measures: |
Primary: ABPM, 28 days | Secondary: sitting PB, 28 days
|
| Sponsor/Collaborators: |
Sponsor: Speedel Pharma Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-11
|
| Completion Date: |
2008-09
|
| Results First Posted: |
|
| Last Update Posted: |
2008-11-21
|
| Locations: |
Dr. John Barton, Ballinasloe, Co Galway, Ireland
|
| URL: |
https://clinicaltrials.gov/show/NCT00561171
|
